Press Release Archive

11.25.2013

Just in Time for Peak Travel Season, Introducing New Robitussin® DM Max Liquid-Filled Capsules

11.21.2013

Pfizer’s XALKORI® Granted Regular FDA Approval

11.21.2013

Pfizer And GSK To Initiate Study Of Novel Combination Therapy In Patients With Melanoma

11.18.2013

Pfizer Announces FDA Approval Of Supplemental Application To Expand XELJANZ® (tofacitinib citrate) Labeling To Include Additional Patient-Reported Outcomes Data For Adults With Moderately To Severely Active Rheumatoid Arthritis

11.14.2013

Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014

11.08.2013

Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE® (sirolimus) In Renal Transplant Recipients

11.05.2013

Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern

11.04.2013

Pfizer Receives FDA Approval For A Prior Approval Supplement For EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII

11.04.2013

JDRF Teams Up with Pfizer’s Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes

10.29.2013

Pfizer Reports Third Quarter 2013 Results

10.28.2013

Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk

10.24.2013

Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend